Figures & data
Table 1 Population and Clinical Characteristics of Particpants
Figure 2 The MoCA score were changed between post- and pre-CPAP OSA patients. (A) Each OSA patient changes. (B) The mean value of MoCA.
![Figure 2 The MoCA score were changed between post- and pre-CPAP OSA patients. (A) Each OSA patient changes. (B) The mean value of MoCA.](/cms/asset/aa2a49aa-f576-4159-b361-225ba818c685/dnss_a_12174277_f0002_c.jpg)
Figure 3 The ESS score were changed between post- and pre-CPAP OSA patients. (A) Each OSA patient changes. (B) The mean value of ESS.
![Figure 3 The ESS score were changed between post- and pre-CPAP OSA patients. (A) Each OSA patient changes. (B) The mean value of ESS.](/cms/asset/6e680e6b-c284-496d-8f0d-f6d57b2474dd/dnss_a_12174277_f0003_c.jpg)
Figure 4 Highly similar spatial distribution patterns of ReHo were found at the group level for healthy controls (A) and OSA patients (pre-CPAP (B) and post-CPAP (C)) in the typical frequency band (0.01–0.1 Hz), slow-4 frequency band (0.027–0.073 Hz), and slow-5 frequency band (0.01–0.027 Hz).
![Figure 4 Highly similar spatial distribution patterns of ReHo were found at the group level for healthy controls (A) and OSA patients (pre-CPAP (B) and post-CPAP (C)) in the typical frequency band (0.01–0.1 Hz), slow-4 frequency band (0.027–0.073 Hz), and slow-5 frequency band (0.01–0.027 Hz).](/cms/asset/b2a08b57-b4fb-4442-98f8-c3f68769cf94/dnss_a_12174277_f0004_c.jpg)
Table 2 Significant Altered ReHo in Typical Frequency Band (0.01–0.1 Hz) Between the Pre-CPAP OSA Patients and HC Groups (Two Sample t-Test)
Figure 5 Two-sample t-test in the typical frequency band (0.01–0.08 Hz) (A). The results were obtained by a 2×2 two-way ANOVA analysis (group: baseline OSA patients and HC; frequency band: slow-4 and slow-5), Main effects of group (B); Main effects of frequency band (C); Interaction between frequency bands and groups (D). The post hoc two-sample t-test for the slow-4 frequency band (0.027–0.073 Hz) (E) and slow-5 frequency band (0.01–0.027 Hz) (F). All results were reported at voxel-level p < 0.01 and cluster-level p < 0.05, GRF corrected.
![Figure 5 Two-sample t-test in the typical frequency band (0.01–0.08 Hz) (A). The results were obtained by a 2×2 two-way ANOVA analysis (group: baseline OSA patients and HC; frequency band: slow-4 and slow-5), Main effects of group (B); Main effects of frequency band (C); Interaction between frequency bands and groups (D). The post hoc two-sample t-test for the slow-4 frequency band (0.027–0.073 Hz) (E) and slow-5 frequency band (0.01–0.027 Hz) (F). All results were reported at voxel-level p < 0.01 and cluster-level p < 0.05, GRF corrected.](/cms/asset/3c87cb6f-61d6-4c63-b42a-45b3203f70d8/dnss_a_12174277_f0005_c.jpg)
Table 3 Significant Altered ReHo in Main Effect of Group (Pre-CPAP OSA and HC Groups)
Table 4 Significant Altered ReHo at Specific Frequency Bands Between the Pre-CPAP OSA Patients and HCs (Two Sample t-Test)
Table 5 Significant Altered ReHo at Typical Frequency Band (0.01–0.1 Hz) Between the Post-CPAP OSA Patients and Pre-CPAP OSA (Paired Sample t-Test)
Table 6 Significant Altered ReHo at Specific Frequency Bands Between the Post- and Pre-CPAP OSA (Paired Sample t-Test)
Figure 6 Pair sample t-test in the typical frequency band (0.01–0.08 Hz) (A), the slow-4 frequency band (0.027–0.073 Hz) (B), and slow-5 frequency band (0.01–0.027 Hz) (C) between pre- and post-CPAP OAS patients. The CPAP treatment-related changes of the ReHo in the three different frequency bands in OSA patients (D). All results were reported at voxel-level p < 0.01 and cluster-level p < 0.05, GRF corrected.
![Figure 6 Pair sample t-test in the typical frequency band (0.01–0.08 Hz) (A), the slow-4 frequency band (0.027–0.073 Hz) (B), and slow-5 frequency band (0.01–0.027 Hz) (C) between pre- and post-CPAP OAS patients. The CPAP treatment-related changes of the ReHo in the three different frequency bands in OSA patients (D). All results were reported at voxel-level p < 0.01 and cluster-level p < 0.05, GRF corrected.](/cms/asset/c9ac1161-a30e-4900-a9a4-d13dffcab2b7/dnss_a_12174277_f0006_c.jpg)
Figure 7 Mean ReHo z-value of HC, pre- and post-CPAP OSA patients in altered brain regions, which were compared before and after CPAP treatment in OSA patients in three different frequency band. (A) typical frequency band; (B) slow-4 band; (C) slow-5 band.
![Figure 7 Mean ReHo z-value of HC, pre- and post-CPAP OSA patients in altered brain regions, which were compared before and after CPAP treatment in OSA patients in three different frequency band. (A) typical frequency band; (B) slow-4 band; (C) slow-5 band.](/cms/asset/2bb39f22-7a50-44f4-8edd-3bbe468287ab/dnss_a_12174277_f0007_c.jpg)
Figure 8 In the pre-CPAP OSA patients, significant correlations between the mean ReHo z-value with between-subgroup differences (pre-CPAP OSA patients vs HC groups) and clinical assessment.
![Figure 8 In the pre-CPAP OSA patients, significant correlations between the mean ReHo z-value with between-subgroup differences (pre-CPAP OSA patients vs HC groups) and clinical assessment.](/cms/asset/72371a48-0c0f-4345-926c-2d79ddccfa66/dnss_a_12174277_f0008_c.jpg)